Reliq Health Technologies (Reliq Health Technologies) COGS-to-Revenue : 0.37 (As of Sep. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Reliq Health Technologies COGS-to-Revenue?

Reliq Health Technologies's Cost of Goods Sold for the three months ended in Sep. 2022 was $0.97 Mil. Its Revenue for the three months ended in Sep. 2022 was $2.60 Mil.

Reliq Health Technologies's COGS to Revenue for the three months ended in Sep. 2022 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Reliq Health Technologies's Gross Margin % for the three months ended in Sep. 2022 was 62.66%.

Reliq Health Technologies COGS-to-Revenue Historical Data

The historical data trend for Reliq Health Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reliq Health Technologies COGS-to-Revenue Chart

Reliq Health Technologies Annual Data

Trend

Dec13

Dec14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

COGS-to-Revenue

Get a 7-Day Free Trial

0.49

0.96

0.85

0.41

0.38

Reliq Health Technologies Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
COGS-to-Revenue	Get a 7-Day Free Trial															0.28	0.26	0.35	0.60	0.37

Reliq Health Technologies COGS-to-Revenue Calculation

Reliq Health Technologies's COGS to Revenue for the fiscal year that ended in Jun. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.539	/	6.679
	=	0.38

Reliq Health Technologies's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.972	/	2.603
	=	0.37

Reliq Health Technologies (OTCPK:RQHTF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Reliq Health Technologies's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.972 / 2.603
	=	62.66 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Reliq Health Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Reliq Health Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Reliq Health Technologies (Reliq Health Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Reliq Health Technologies Inc (OTCPK:RQHTF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

175 Longwood Rd S., Suite 406A, Hamilton, ON, CAN, L8P 0A1

Website

https://www.reliqhealth.com

Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery. The firm earns through the supply of mobile device management (MDM) solutions for mobile devices and subscriptions of the iUGO CARE platform to healthcare client. The firm is based in Canada.